Altre lingue Genovis AB

Azioni

GENO

SE0002485979

Tempo differito Nasdaq Stockholm Altri mercati azionari 12:19:58 30/04/2024			Variaz. 5gg	Var. 1 gen.
27,5 ^SEK	-1,96%		-0,54%	-47,12%

14/03	Carthesian Therapeutics rescinde il contratto di licenza con Genovis AB (Publ.)	CI
15/02	Genovis AB (publ.) riporta i risultati degli utili per il quarto trimestre conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Genovis Annual Report 2023 published	24/04
NOTICE CONVENING THE 2024 ANNUAL GENERAL MEETING	09/04
Carthesian Therapeutics terminates Genovis Licence Agreement	14/03
Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement	14/03
Genovis Q4 2023 - Soft ending but promising start	19/02
Genovis AB (publ.) Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	15/02
Year-end report January-December 2023	15/02
Genovis AB (publ.) Reports Earnings Results for the Full Year Ended December 31, 2023	15/02
Genovis to Get $1 Million Milestone Payment for Xork Development	13/02
Genovis to receive USD 1 million in milestone compensation related to the development of the Xork™ enzyme	13/02
Genovis AB changes Certified Adviser to Carnegie Investment Bank AB (publ)	30/11
Genovis Q3 2023 - Solid growth and profitability, Xork timeline remains on track	16/11
Genovis AB (publ.) Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11
Genovis Q2 2023 - Strong growth and expanding EBIT margin	25/08/23
Half-Yearly Report January-June 2023	24/08/23
Genovis AB (publ.) Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/08/23
Genovis launch Innovative IgM-Specific Protease with Wide-Ranging Applications in Life Science Markets	02/06/23
Genovis Launch Innovative Igm-Specific Protease with Wide-Ranging Applications in Life Science Markets	02/06/23
Genovis Q1 2023 - Strongest report to date	17/05/23
Communiqué from Genovis AB (publ) Annual General Meeting May 16, 2023	16/05/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Genovis AB

Azioni

GENO

SE0002485979

Altre lingue

Filtri